作者：
Anders,Bjartell [1]
;
Nicolaas,Lumen [2]
;
Pablo,Maroto [3]
;
Thomas,Paiss [4]
;
Francisco,Gomez-Veiga [5]
;
Alison,Birtle [6]
;
Gero,Kramer [7]
;
Ewa,Kalinka [8]
;
Dominique,Spaëth [9]
;
Susan,Feyerabend [10]
;
Vsevolod,Matveev [11]
;
Florence,Lefresne [12]
;
Martin,Lukac [13]
;
Robert,Wapenaar [14]
;
Luis,Costa [15]
;
Simon,Chowdhury [16]
作者单位：
Department of Urology, Skåne University Hospital Malmö, Jan Waldenströms gata 5, SE 205 02, Malmö, Sweden. anders.bjartell@med.lu.se.
[1]
Department of Translational Medicine, Medical Faculty, Lund University, Malmö, Sweden. anders.bjartell@med.lu.se.
[2]
Department of Urology, Ghent University Hospital, Ghent, Belgium.
[3]
Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
[4]
Urologie team Ulm, Ulm, Germany.
[5]
Urology Department and Kidney Transplant Unit, Translational Research Group of Urology GITUR-IBSAL, Salamanca University Hospital, Salamanca, Spain.
[6]
Royal Preston Hospital, Preston, UK.
[7]
Department of Urology, Medical University of Vienna, Vienna, Austria.
[8]
Clinic of Oncology, Polish Mother's Memorial Hospital, Research Institute, Lodz, Poland.
[9]
Centre d'Oncologie de Gentilly, Nancy, France.
[10]
Studienpraxis Urologie, Nürtingen, Germany.
[11]
N.N. Blokhin National Cancer Research Center, Moscow, Russia.
[12]
EMEA Oncology, Janssen Pharmaceutica N.V., Beerse, Belgium.
[13]
Parexel International Czech Republic s.r.o, on behalf of Janssen Pharmaceutica N.V., Beerse, Belgium.
[14]
Janssen-Cilag B.V., Breda, The Netherlands.
[15]
Oncology Division, Faculdade de Medicina, Hospital de Santa Maria, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal.
[16]
Guy's and St Thomas' NHS Foundation Trust and Sarah Cannon Research Institute, London, UK.
[17]
DOI
10.1007/s11523-021-00807-4
PMID
33826036
发布时间
2024-04-02
换一批
换一批
